Story perspectives
Abridge Enhances AI Tool with NEJM and JAMA Integration
4/18/2026
1 of 3
Abridge Enhances Support
- Abridge expands its clinical decision support tool through partnerships with medical publishers to deliver timely information during patient interactions.
- Abridge will soon integrate content from the New England Journal of Medicine (NEJM) and the Journal of the American Medical Association (JAMA).
- The AI tool will annotate information sources to promote trust and safety against misinformation.
- Clinicians will maintain control while gaining improved access to data, supported by 250 health systems.
1 / 3
